Source:http://linkedlifedata.com/resource/pubmed/id/10068112
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0034693,
umls-concept:C0087113,
umls-concept:C0181904,
umls-concept:C0205197,
umls-concept:C0205314,
umls-concept:C0220825,
umls-concept:C0227525,
umls-concept:C0336562,
umls-concept:C0596972,
umls-concept:C0679622,
umls-concept:C0728873,
umls-concept:C0920569,
umls-concept:C1511790,
umls-concept:C1521743,
umls-concept:C1704646
|
pubmed:issue |
2
|
pubmed:dateCreated |
1999-4-29
|
pubmed:abstractText |
There is an urgent need for an effective bioartificial liver system to bridge patients with fulminant hepatic failure to liver transplantation or to regeneration of their own liver. Recently, we proposed a bioreactor with a novel design for use as a bioartificial liver (BAL). The reactor comprises a spirally wound nonwoven polyester fabric in which hepatocytes are cultured (40 x 10(6) cells/ml) as small aggregates and homogeneously distributed oxygenation tubing for decentralized oxygen supply and CO2 removal. The aims of this study were to evaluate the treatment efficacy of our original porcine hepatocyte-based BAL in rats with fulminant hepatic failure due to liver ischemia (LIS) and to monitor the viability of the porcine hepatocytes in the bioreactor during treatment. The latter aim is novel and was accomplished by applying a new species-specific enzyme immunoassay (EIA) for the determination of porcine alpha-glutathione S-transferase (alpha-GST), a marker for hepatocellular damage.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0168-8278
|
pubmed:author |
pubmed-author:ChamuleauR ARA,
pubmed-author:DaalhuisenJJ,
pubmed-author:DoyleSS,
pubmed-author:FlendrigL MLM,
pubmed-author:HasselJJ,
pubmed-author:JörningG GGG,
pubmed-author:KiltyC GCG,
pubmed-author:LadigesN CNC,
pubmed-author:LubsH JHJ,
pubmed-author:SommeijerDD,
pubmed-author:la SoeJ WJW,
pubmed-author:te VeldeA AAA
|
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
311-20
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10068112-Animals,
pubmed-meshheading:10068112-Equipment Design,
pubmed-meshheading:10068112-Evaluation Studies as Topic,
pubmed-meshheading:10068112-Glutathione Transferase,
pubmed-meshheading:10068112-Immunoenzyme Techniques,
pubmed-meshheading:10068112-Ischemia,
pubmed-meshheading:10068112-Isomerism,
pubmed-meshheading:10068112-Liver, Artificial,
pubmed-meshheading:10068112-Liver Circulation,
pubmed-meshheading:10068112-Male,
pubmed-meshheading:10068112-Rats,
pubmed-meshheading:10068112-Rats, Wistar,
pubmed-meshheading:10068112-Species Specificity,
pubmed-meshheading:10068112-Swine
|
pubmed:year |
1999
|
pubmed:articleTitle |
Evaluation of a novel bioartificial liver in rats with complete liver ischemia: treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability.
|
pubmed:affiliation |
Department of Experimental Internal Medicine, University of Amsterdam, Academic Medical Center, The Netherlands. Flendrig@DDS.NL
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|